# US 2013/0273183 A1 · 2-Pyrimidine Thioesters and Thiocarbonates as Skin Brightening Agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0273183 A1
- Document ID: US20130273183A1
- Status: Published application
- Kind: A1
- Application number: 13/446,240
- Filed: 2012-04-13
- Published: 2013-10-17
- Earliest claimed: 2012-04-13
- Assignees: Eastman Chemical Company
- Inventors: Stephanie Kay Clendennen; Liu Deng; Neil Warren Boaz
- Web page: https://patentgrep.com/patent/US20130273183A1

## CPC

- A61K 8/4926: {having six membered rings}
- A61Q 19/02: for chemically bleaching or whitening the skin
- A61K 2800/782: Enzyme inhibitors; Enzyme antagonists
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

2-Pyrimidine thioesters and thiocarbonates are disclosed as effective skin brightening agents. These compounds may be formulated with dermatologically acceptable carriers to form skin brightening compositions. Methods for brightening skin and for inhibiting melanogenesis using these agents are also disclosed.

## Claims

### Claim 1

A composition for brightening skin comprising:
(a) a 2-pyrimidine thioester or thiocarbonate compound having the general formula 1:
wherein
R is selected from the group consisting of a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl or alkoxy group; a substituted or unsubstituted C3-C8 cycloalkyl or cycloalkoxy group; a substituted or unsubstituted C6-C20 carbocyclic aryl or aryloxy group; and a substituted or unsubstituted C4-C20 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen; a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl group, wherein the branching and/or substitution of R1 and R2 may connect to form a ring; a substituted or unsubstituted C3-C8 cycloalkyl group; a substituted or unsubstituted C6-C10 carbocyclic aryl group; a substituted or unsubstituted C4-C10 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; a hydroxyl group; a C1-C6 alkoxy group; a carboxyl group; an amino group; a C1-C15 aminocarbonyl group; a C1-C15 amido group; a cyano group; a C2-C6 alkoxycarbonyl group; a C2-C6-alkanoyloxy group; a thiol group; a thioether group; a C2-C10 dialkylamino group; a C3-C15 trialkylammonium group; and a halogen, and
(b) a dermatologically acceptable carrier.

### Claim 2 (depends on 1)

The composition according to claim 1, wherein
R is selected from the group consisting of a substituted or unsubstituted, branched- or straight-chain saturated C1-C22 alkyl group or alkoxy group; a substituted or unsubstituted, branched- or straight-chain C2-C22 alkenyl or alkenyloxy group; a substituted or unsubstituted, branched- or straight-chain C4-C22 dienyl group; a substituted or unsubstituted C3-C8 cycloalkyl or cycloalkoxy group; a substituted or unsubstituted C6-C20 carbocyclic aryl or aryloxy group; and a substituted or unsubstituted C4-C20 heteroaryl group; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen and a straight- or branched-chain C1-C6 alkyl or alkenyl group.

### Claim 3 (depends on 1)

The composition according to claim 1, wherein
R is selected from the group consisting of a C1-C10 alkyl group or alkoxy group, a C2-C10 alkenyl or alkenyloxy group, a C4-C10 dienyl group, a C3-C8 cycloalkyl or cycloalkoxy group, a C6-C12 carbocyclic aryl or aryloxy group, and a C4-C10 heteroaryl group; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen and a C1-C6 alkyl or alkenyl group.

### Claim 4 (depends on 1)

The composition according to claim 1, wherein R1, R2, and R3 are hydrogen.

### Claim 5 (depends on 1)

The composition according to claim 1, wherein R is selected from the group consisting of methyl, ethyl, 1,1-dimethylethyl, n-pentyl, phenyl, 3-pyridyl, 4-pyridyl, and ethoxy; and R1, R2, and R3 are hydrogen.

### Claim 6 (depends on 1)

The composition according to claim 1, which comprises from 0.01 to 10% by weight of the 2-pyrimidine thioester or thiocarbonate compound.

### Claim 7 (depends on 1)

The composition according to claim 1, which comprises from 0.1 to 5% by weight of the 2-pyrimidine thioester or thiocarbonate compound.

### Claim 8 (depends on 1)

The composition according to claim 1, which further comprises at least one compound selected from the group consisting of retinol, retinyl esters, tetronic acid, tetronic acid derivatives, hydroquinone, kojic acid, gallic acid, arbutin, 4-hydroxybenzyl alcohol or esters thereof, α-hydroxy acids, niacinamide, pyridoxine, ascorbic acid, vitamin E or derivatives thereof, aloe, salicylic acid, benzoyl peroxide, witch hazel, caffeine, zinc pyrithione, and fatty acid esters of ascorbic acid.

### Claim 9

A method for brightening skin, comprising topically applying a composition to skin in need of brightening, wherein the composition comprises:
(a) a 2-pyrimidine thioester or thiocarbonate compound having the general formula 1:
wherein
R is selected from the group consisting of a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl or alkoxy group; a substituted or unsubstituted C3-C8 cycloalkyl or cycloalkoxy group; a substituted or unsubstituted C8-C20 carbocyclic aryl or aryloxy group; and a substituted or unsubstituted C4-C20 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen; a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl group, wherein the branching and/or substitution of R1 and R2 may connect to form a ring; a substituted or unsubstituted C3-C8 cycloalkyl group; a substituted or unsubstituted C6-C10 carbocyclic aryl group; a substituted or unsubstituted C4-C10 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; a hydroxyl group; a C1-C6 alkoxy group; a carboxyl group; an amino group; a C1-C15 aminocarbonyl group; a C1-C15 amido group; a cyano group; a C2-C6 alkoxycarbonyl group; a C2-C6-alkanoyloxy group; a thiol group; a thioether group; a C2-C10 dialkylamino group; a C3-C15 trialkylammonium group; and a halogen, and
(b) a dermatologically acceptable carrier.

### Claim 10 (depends on 9)

The method according to claim 9, wherein R is selected from the group consisting of methyl, ethyl, 1,1-dimethylethyl, n-pentyl, phenyl, 3-pyridyl, 4-pyridyl, or ethoxy; and R1, R2, and R3 are hydrogen.

### Claim 11 (depends on 9)

The method according to claim 9, wherein the composition comprises from 0.1 to 5% by weight of the 2-pyrimidine thioester or thiocarbonate compound.

### Claim 12 (depends on 1)

The method according to claim 1, wherein the composition further comprises at least one compound selected from the group consisting of retinol, retinyl esters, tetronic acid, tetronic acid derivatives, hydroquinone, kojic acid, gallic acid, arbutin, 4-hydroxybenzyl alcohol and esters thereof, α-hydroxy acids, niacinamide, pyridoxine, ascorbic acid, vitamin E and derivatives thereof, aloe, salicylic acid, benzoyl peroxide, witch hazel, caffeine, zinc pyrithione, and fatty acid esters of ascorbic acid.

### Claim 13

A method for inhibiting melanogenesis, comprising contacting melanocytes with a 2-pyrimidine thioester or thiocarbonate compound having the general formula 1:
wherein
R is selected from the group consisting of a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl or alkoxy group; a substituted or unsubstituted C3-C8 cycloalkyl or cycloalkoxy group; a substituted or unsubstituted C6-C20 carbocyclic aryl or aryloxy group; or a substituted or unsubstituted C4-C20 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen; a substituted or unsubstituted, branched- or straight-chain, saturated, unsaturated, or polyunsaturated C1-C22 alkyl group, wherein the branching and/or substitution of R1 and R2 may connect to form a ring; a substituted or unsubstituted C3-C8 cycloalkyl group; a substituted or unsubstituted C6-C10 carbocyclic aryl group; a substituted or unsubstituted C4-C10 heterocyclic group containing one or more heteroatoms selected from the group consisting of sulfur, nitrogen, and oxygen; a hydroxyl group; a C1-C6 alkoxy group; a carboxyl group; an amino group; a C1-C15 aminocarbonyl group; a C1-C15 amido group; a cyano group; a C2-C6 alkoxycarbonyl group; a C2-C6-alkanoyloxy group; a thiol group; a thioether group; a C2-C10 dialkylamino group; a C3-C15 trialkylammonium group; and a halogen.

### Claim 14 (depends on 13)

The method according to claim 13, wherein
R is selected from the group consisting of a substituted or unsubstituted, branched- or straight-chain saturated C1-C22 alkyl group or alkoxy group; a substituted or unsubstituted, branched- or straight-chain C2-C22 alkenyl or alkenyloxy group; a substituted or unsubstituted, branched- or straight-chain C4-C22 dienyl group; a substituted or unsubstituted C3-C8 cycloalkyl or cycloalkoxy group; a substituted or unsubstituted C6-C20 carbocyclic aryl or aryloxy group; and a substituted or unsubstituted C4-C20 heteroaryl group; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen and a straight- or branched-chain C1-C6 alkyl or alkenyl group.

### Claim 15 (depends on 13)

The method according to claim 13, wherein
R is selected from the group consisting of a C1-C10 alkyl group or alkoxy group, a C2-C10 alkenyl or alkenyloxy group, a C4-C10 dienyl group, a C3-C8 cycloalkyl or cycloalkoxy group, a C6-C12 carbocyclic aryl or aryloxy group, and a C4-C10 heteroaryl group; and
R1, R2, and R3 are each independently selected from the group consisting of hydrogen and a C1-C8 alkyl or alkenyl group.

### Claim 16 (depends on 13)

The method according to claim 13, wherein R1, R2, and R3 are hydrogen.

### Claim 17 (depends on 13)

The method according to claim 13, wherein R is selected from the group consisting of methyl, ethyl, 1,1-dimethylethyl, n-pentyl, phenyl, 3-pyridyl, 4-pyridyl, or ethoxy; and R1, R2, and R3 are hydrogen.
